Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
CENA AKCJI
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionSofos Investments, Inc.
Latest Disclosed Ownership47,971 shares
Latest Disclosed Value $ 7,327,570
Sofos Investments, Inc. reports 0.96% decrease in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On May 8, 2026 - Sofos Investments, Inc. filed a 13F-HR form disclosing ownership of 47,971 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $6,164,274 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 48,437 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -0.96% during the quarter. The current value of the position is $5,804,491 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F NOVARTIS AG FSPONSORED ADR 1 ADR REPS 1 ORD SHS AMERICAN DEPOSITORY 66987V109 47,971 -466 -0.96 7,328 9.72 1.3039
2026-02-13 2025-12-31 13F NOVARTIS AG FSPONSORED ADR 1 ADR REPS 1 ORD SHS AMERICAN DEPOSITORY 66987V109 48,437 2,956 6.50 6,678 14.51 1.2854
2025-11-14 2025-09-30 13F NOVARTIS AMERICAN DEPOSITORY 66987V109 45,481 4,353 10.58 5,832 27.23 1.1528
2025-04-30 2025-03-31 13F NOVARTIS AG FSPONSORED ADR 1 ADR REPS 1 ORD SHS AMERICAN DEPOSITORY 66987V109 41,128 2,061 5.28 4,585 10.25 0.9998
2024-08-06 2024-06-30 13F NOVARTIS AMERICAN DEPOSITORY 66987V109 39,067 5,102 15.02 4,159 21.26 1.0385
2024-06-26 2024-03-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 33,965 0 0.00 3,429 0.00 0.9648
2024-05-13 2024-03-31 13F Novartis AG ADR SPONSORED ADR 66987V109 36,244 2,279 3,506 0.8985
2024-06-26 2023-12-31 13F/A-1 NOVARTIS AG F AMERICAN DEPOSITORY 66987V109 33,965 33,921 77,093.18 3,430 85,625.00 0.9635
2024-02-15 2023-12-31 13F NOVARTIS International Equities 66987V109 44 0 4 0.0000
2023-11-16 2023-09-30 13F NOVARTIS International Equities 66987V109 44 -57 -56.44 4 -63.64 0.0000
2023-08-09 2023-06-30 13F NOVARTIS International Equities 66987V109 101 9 9.78 12 175.00 0.0314
2023-05-12 2023-03-31 13F NOVARTIS International Equities 66987V109 92 1 1.10 5 -60.00 0.1491
2023-02-15 2022-12-31 13F NOVARTIS International Equities 66987V109 91 -1,657 -94.79 11 150.00 0.0563
2022-11-03 2022-09-30 13F NOVARTIS International Equities 66987V109 1,748 -462 -20.90 5 -42.86 0.1582
2022-08-05 2022-06-30 13F NOVARTIS A G ADR 66987V109 2,210 -78 -3.41 8 0.00 0.2350
2022-05-13 2022-03-31 13F NOVARTIS ADR 66987V109 2,288 1,679 275.70 7 0.2054
2022-02-11 2021-12-31 13F NOVARTIS A G ADR 66987V109 609 609 0 0.0007
2021-11-12 2021-09-30 13F NOVARTIS A G ADR 66987V109 0 0 0 0.0386
2021-08-11 2021-06-30 13F NOVARTIS A G ADR 66987V109 0 0 0 0.0326
2021-05-17 2021-03-31 13F NOVARTIS A G ADR 66987V109 0 -19 -100.00 0 -100.00 0.0008
2021-02-16 2020-12-31 13F NOVARTIS A G ADR 66987V109 19 19 2 0.0018
2020-08-13 2020-06-30 13F NOVARTIS A G ADR 66987V109 0 -113 -100.00 0 -100.00
2020-05-12 2020-03-31 13F NOVARTIS A G ADR 66987V109 113 48 73.85 9 -90.53 0.0288
2020-02-28 2019-12-31 13F NOVARTIS A G ADR 66987V109 65 -23 -26.14 95 1,087.50 0.0654
2019-10-15 2019-09-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 88 -72 -45.00 8 -46.67 0.0069
2019-07-26 2019-06-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 160 -183 -53.35 15 -54.55 0.0123
2019-04-19 2019-03-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 343 177 106.63 33 135.71 0.0267
2018-10-31 2018-09-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 166 11 7.10 14 7.69 0.0147
2018-08-14 2018-06-30 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 155 2 1.31 13 8.33 0.0122
2018-05-23 2018-03-31 13F NOVARTIS A G SPONSORED ADR ADR 66987V109 153 153 12 0.0123
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.